Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01926626Phase 2Completed
A Phase 2 trial of moclobemide in nicotine dependence. Started Sep 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01926626.